Jpmorgan Chase & CO Jupiter Wellness, Inc. Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
Shares
3 transactions
Others Institutions Holding JUPW
# of Institutions
58Shares Held
5.16MCall Options Held
10.1KPut Options Held
11.8K-
Glenview Trust CO Louisville, KY2MShares$5.84 Million0.12% of portfolio
-
Black Rock Inc. New York, NY678KShares$1.98 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA459KShares$1.34 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA396KShares$1.16 Million0.0% of portfolio
-
M Holdings Securities, Inc. Portland, OR152KShares$445,1910.02% of portfolio
About Jupiter Wellness, Inc.
- Ticker JUPW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 22,095,000
- Market Cap $64.5M
- Description
- Jupiter Wellness, Inc. develops cannabidiol (CBD) based medical therapeutics and wellness products. The company's clinical pipeline includes CaniDermRX (JW-100), a novel topical formulation containing CBD and aspartame for the treatment of eczema, dermatitis, and actinic keratosis; JW-101, a prescription product for the treatment of burns; and J...